| |
|
|
|
|
|
Company Logo
|
Company:
Date:
November 18, 2010
|
|
|
|
|
|
|
|
|
|
The AFP ELISA kit is used for the quantitative measurement of AFP in human serum or plasma. Elevation of serum AFP to abnormally high values occurs in several malignant diseases, most notably nonseminomatous testicular cancer and primary hepatocellular carcinoma. In the case of nonseminomatous testicular cancer, a direct relationship has been observed between the incidence of elevated AFP levels and the stage of disease. Elevated AFP levels have also been observed in patients diagnosed with seminoma with nonseminomatous elements, but not in patients with pure seminoma. In addition, elevated
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|
|
|
|
|
The is an enzyme immunoassay for the quantitative determination of Beta-2 Microglobulin (B2MG) Concentration in Human Serum, Plasma and Urine. Human Beta-2 Microglobulin (B2MG) is an 11.8 kD protein identical to the light chain of the HLA-A, -B, and –C antigen. B2MG is expressed on nucleated cells, and is found at low levels in the serum and urine of normal individuals. B2MG concentrations are increased in inflammatory diseases, some viral diseases, renal dysfunction, and autoimmune diseases. A number of publications are available which explain the interpretation of B2MG serum levels in as
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|
|
|
|
|
The CA 125 ELISA used for the quantitative determination of the Cancer Antigen CA125 concentration in human serum. Cancer Antigen 125 (CA125) is a surface antigen associated with epithelial ovarian cancer. In serum, CA125 is associated with a high molecular weight glycoprotein. Published studies have indicated that elevated serum CA125 levels can be found in individuals with serious endometroid, clear-cell and undifferentiated ovarian carcinoma. Serial determinations of serum CA125 as well as pelvic examination increase the test specificity. Serum CA125 concentration may be useful in monitor
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|
|
|
|
|
The CA15-3 for the quantitative determination of the Cancer Antigen CA15-3 concentration in human serum. CA15-3 is most useful for monitoring patients post-operatively for recurrence, particularly metastatic diseases. 96 of patients with local and systemic recurrence have elevated CA15-3, which can be used to predict recurrence earlier than radiological and clinical criteria. A 25 increase in the serum CA15-3 is associated with progression of carcinoma. A 50 decrease in serum CA15-3 is associated with response to treatment. CA15-3 is more sensitive than CEA in early detection of breast can
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|
|
|
|
|
The CA 19-9 ELISA test system is an enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of the Cancer Antigen CA 19-9 concentration in human serum. A group of mucin type glycoprotein Sialosyl Lewis Antigens (SLA), such as CA19-9 and CA19-5, have come to be recognized as circulating cancer associated antigens for gastrointestinal cancer. CA19-9 represents the most important and basic carbohydrate tumor marker. The immunohistologic distribution of CA19-9 in tissues is consistent with the quantitative determination of higher CA19-9 concentrations in cancer than in normal
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|
|
|
|
|
The CEA ELISA kit is used for the quantitative measurement of CEA in human serum or plasma. Carcinoembryonic antigen (CEA), a 180 kD intercellular adhesion molecule expressed in high concentrations in the fetus but normally not found in adult serum because the synthesis of this protein ceases after birth. However reappear in a high concentration in the sera of patients with colorectal (57), gastric (41), hepatocellular (45), pancreatic (59) and biliary (59) carcinoma. The serum concentration of CEA can also be elevated in benign diseases of the colorectum (inflammatory bowel disease 17), stom
|
Company:
Date:
July 06, 2009
|
|
|
|
|
|
|
|
|
|
The CellSearch™ Circulating Tumor Cell (CTC) Kit is intended for the immunomagnetic selection, identification, and enumeration of CTCs of epithelial origin in whole blood.
Features Include:
Ready-to-use ferrofluid-based capture reagent and
immunofluorescent reagents for 16 complete tests
Preloaded reagent tray for easy loading onto
CellTracks® AutoPrep® System
Embedded data button in reagent holder to assist in
kit lot tracking and reagent use monitoring
Specially designed cartridges for optimal CTC isolation and analysis
Designed for use with the CellTracks® AutoPrep® System and the
CellTrack
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
The CellSearch™ CTC Control kit maintains quality control for reagents, instruments, and operator techniques.
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
URMC LABS is a GxP central lab facility providing a full range of services to biotechnology, pharmaceutical,CROs and investigator sites. Analytical services include a comprehensive test menu for Clinical and Anatomic Pathology Laboratory Medicine. Other services to support your trial include project management, kit production, logistics and sample storage. New York State [CLIA] licensed and CAP accredited.
|
Company:
Date:
July 23, 2009
|
|
|
|
|
|